Press Releases Hyperion DeFi, Inc.

Equities

HYPD

US30234E2037

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 12:13:29 2025-07-15 pm EDT			5-day change	1st Jan Change
12.22 ^USD	+1.62%		+5.54%	+4.45%

Jul. 02	Eyenovia, Inc. will Change its Name to Hyperion DeFi, Inc	CI
Jul. 02	Eyenovia, Inc. will Change its Ticker to HYPD from EYEN	CI

Press Releases

Eyenovia Announces Rebranding and Corporate Name Change to Hyperion DeFi, Inc.	Jul. 02	AQ
Eyenovia Adds $10 Million in HYPE to its Treasury Holdings in Preparation for Strategic Onchain Engagement	Jun. 30	AQ
Eyenovia Announces Co-Branded Validator with Kinetiq	Jun. 26	AQ
Eyenovia Announces Co-Branded Validator with Kinetiq	Jun. 25	AQ
Eyenovia Announces Closing of $50 Million Private Placement, Successful Accumulation of More Than One Million HYPE Tokens, and Update on its Optejet Development Program	Jun. 23	AQ
Eyenovia Announces Appointment of a Strategic Advisor for Digital Asset Treasury Strategy and Amendment of Debt Agreement with Avenue Capital Group	Jun. 18	AQ
Eyenovia Announces $50 Million Investment to Launch a Hyperliquid (HYPE token) Cryptocurrency Treasury Reserve Strategy	Jun. 17	AQ
Eyenovia : Investor Presentation June 11 2025	Jun. 11	PU
Peraso Inc. (NASDAQ: PRSO): "The Convergence of Technical Momentum and Military Innovation" - More Stocks Inside	May. 21	AQ
Eyenovia Provides Updates on Potential Merger with Betaliq and Development of the Optejet User Filled Device (UFD), and Reports First Quarter 2025 Financial Results	May. 19	AQ
Eyenovia Provides Development Update on Optejet User Filled Device (UFD)	Apr. 10	AQ
Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq	Mar. 20	AQ
Eyenovia Regains Compliance with All Nasdaq Continued Listing Requirements	Feb. 26	AQ
Eyenovia, Inc. Announces Debt Restructuring Including Amendment to Senior Secured Debt, Improving Cash Runway to Allow for the Evaluation of Strategic Alternatives	Feb. 24	AQ
Eyenovia Announces Progress on Next-Generation User-Filled Optejet Dispensing Device	Feb. 05	AQ
Eyenovia Announces 1-for-80 Reverse Stock Split	Jan. 28	AQ
Eyenovia Announces Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend Eyenovia Stockholders Vote “FOR” Proposed Reverse Stock Split at Upcoming Special Meeting of Stockholders	Jan. 15	AQ
Eyenovia Engages Chardan as Advisor for Review of Strategic Alternatives	Jan. 06	AQ
Eyenovia, Inc. Announces Pricing of $1.9 Million Registered Direct Offering	Dec. 09	AQ
Eyenovia : Announces Pricing of $1.9 Million Registered Direct Offering Form 8 K	Dec. 09	PU
Eyenovia, Inc. Announces Pricing of $1.9 Million Registered Direct Offering	Dec. 06	AQ
Eyenovia : Announces Pricing of $1.3 Million Registered Direct Offering Form 8 K	Nov. 26	PU
Eyenovia, Inc. Announces Pricing of $1.3 Million Registered Direct Offering	Nov. 25	AQ
Eyenovia Provides Update on Restructuring Efforts	Nov. 22	AQ
Eyenovia Provides Update on Phase 3 CHAPERONE Study	Nov. 18	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Hyperion DeFi, Inc.

Equities

HYPD

US30234E2037

Pharmaceuticals

Press Releases

Filters